MRSA - Overview
Alternative Names
Methicillin-resistant Staphylococcus aureus; Community-acquired MRSA (CA-MRSA); Hospital-acquired MRSA (HA-MRSA)
Definition of MRSA :
Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterial infection that is highly resistant to some antibiotics.
Causes, incidence, and risk factors:
MRSA is caused by a strain of Staphylococcus aureus (S. aureus) bacteria. S. aureus is a common type of bacteria that normally lives on the skin and sometimes in the nasal passages. MRSA refers to S. aureus strains that do not respond to the antibiotics normally used to cure staph infections.
The bacteria can cause infection when they enter the body through a cut, sore, catheter, or breathing tube. The infection can be minor and local (for example, a pimple), or more serious (involving the heart, blood, or bone).
Serious staph infections are more common in people with weak immune systems. This includes patients in hospitals and long-term care facilities and those receiving kidney dialysis.
MRSA infections are grouped into two types:
- Healthcare-associated MRSA (HA-MRSA) infections occur in people who are or have recently been in the hospital. Those who have been hospitalized or had surgery within the past year are at increased risk. MRSA bacteria are responsible for a large percentage of hospital-acquired staph infections.
- Community-associated MRSA (CA-MRSA) infections are ones that occur in otherwise healthy people who have not recently been in the hospital. The infections have occurred among athletes who share equipment or personal items (such as towels or razors) and children in daycare facilities. Members of the military and those who get tattoos are also at risk. The number of CA-MRSA cases is increasing.
- Reviewed last on: 9/28/2008
- David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and Jatin M. Vyas, PhD, MD, Instructor in Medicine, Harvard Medical School, Assistant in Medicine, Division of Infectious Disease, Massachusetts General Hospital. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
References
Siegel JD, Rhinehart E, Jackson M, Chiarello L; Healthcare Infection Control Practices Advisory Committee. Management of multi-drug resistant organisms in healthcare settings, 2006. US Centers for Disease Control and Prevention. Accessed January 25, 2008.
Nicolle L. Community-acquired MRSA: a practitioner's guide. CMAJ. 2006;175:145.
Centers for Disease Control and Prevention. Epidemiology and management of MRSA in the Community. October 26, 2007. Accessed January 25, 2008.